Stockscreener 앱 받기
7.44
3.12%
-0.24
시간 외 거래:
7.49
0.05
+0.67%
전일 마감가:
$7.68
열려 있는:
$7.62
하루 거래량:
41,546
Relative Volume:
0.36
시가총액:
$376.82M
수익:
-
순이익/손실:
$-25.50M
주가수익비율:
-9.6623
EPS:
-0.77
순현금흐름:
$-30.10M
1주 성능:
-1.98%
1개월 성능:
+18.47%
6개월 성능:
+38.03%
1년 성능:
+148.00%
1일 변동 폭
$7.3517
$7.735
1주일 범위
$7.3517
$7.90
52주 변동 폭
$2.6801
$8.00
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
EPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
7.44 | 388.98M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-26 | 개시 | H.C. Wainwright | Buy |
| 2025-06-16 | 개시 | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | 개시 | Craig Hallum | Buy |
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc 주식(EPRX)의 최신 뉴스
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Up 0.3% – Here’s What Happened - Defense World
(EPRX.WT.A) Advanced Equity Analysis - Stock Traders Daily
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Stock Trading Blueprint - Stock Traders Daily
(EPRX) Comprehensive Trading Strategy Report (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Daily Stock Insights - Stock Traders Daily
Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Short Interest Up 30.1% in December - MarketBeat
Trading (EPRX) With Integrated Risk Controls (EPRX:CA) - Stock Traders Daily
How the (EPRX.WT.A) price action is used to our Advantage - Stock Traders Daily
(EPRX) Equity Market Report (EPRX:CA) - Stock Traders Daily
562,500 Non-Voting Class B Shares of Eupraxia Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - marketscreener.com
Can Eupraxia Pharmaceuticals Inc. stock sustain institutional interest2025 Major Catalysts & Low Drawdown Trading Techniques - Улправда
Will Eupraxia Pharmaceuticals Inc. stock reach Wall Street targetsEntry Point & Community Verified Swing Trade Signals - Улправда
(EPRX) Advanced Trading Insights (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Why Eupraxia Pharmaceuticals Inc. stock is a must watch in 2025Quarterly Trade Report & Long-Term Safe Return Strategies - Улправда
Moving Averages: Why Eupraxia Pharmaceuticals Inc. stock is a must watch in 2025July 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolutionTrade Signal Summary & Short-Term High Return Ideas - Улправда
Can Eupraxia Pharmaceuticals Inc. stock beat analyst upgradesMarket Movement Recap & Free Weekly Chart Analysis and Trade Guides - Улправда
Stock Report: Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidanceJuly 2025 Price Swings & Long-Term Safe Return Strategies - Улправда
Why Eupraxia Pharmaceuticals Inc. stock could see breakout soonDay Trade & Risk Controlled Stock Pick Alerts - Улправда
Aug Decliners: Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Historical Comparison & Daily Chart Pattern Signals - Улправда
Aug Final Week: How Eupraxia Pharmaceuticals Inc. stock valuations compare to rivalsTrend Reversal & High Accuracy Investment Entry Signals - Улправда
What insider trading reveals about Eupraxia Pharmaceuticals Inc. stock - DonanımHaber
How Eupraxia Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Macro Moves & AI Driven Price Predictions - DonanımHaber
How geopolitical risks impact Eupraxia Pharmaceuticals Inc. (X43) stockWeekly Trade Review & Risk Controlled Swing Alerts - Улправда
Market Review: Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolutionTrade Entry Summary & Growth Oriented Trade Recommendations - Улправда
(EPRX.WT.A) Stock Evaluation Report - Stock Traders Daily
Why Eupraxia Pharmaceuticals Inc. stock remains a top recommendationProduct Launch & Intraday High Probability Alerts - DonanımHaber
Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidance2025 Risk Factors & Daily Market Momentum Tracking - Улправда
Bearish Setup: Why Eupraxia Pharmaceuticals Inc. stock could see breakout soon2025 Institutional Moves & Low Risk Entry Point Tips - Улправда
(EPRX.WT.A) Strategic Equity Report - Stock Traders Daily
How to Take Advantage of moves in (EPRX) (EPRX:CA) - news.stocktradersdaily.com
FY2025 Earnings Estimate for EPRX Issued By Lifesci Capital - MarketBeat
(EPRX.WT.A) Risk-Controlled Trading Report - news.stocktradersdaily.com
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Shares Down 0.3% – Here’s Why - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Raised to Strong-Buy at Lifesci Capital - Defense World
New Highs: How Eupraxia Pharmaceuticals Inc stock reacts to global recession fears2025 Historical Comparison & Fast Moving Trade Plans - moha.gov.vn
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to "Strong-Buy" at Lifesci Capital - MarketBeat
Eupraxia Pharmaceuticals Inc. (EPRXF) Competitors - Meyka
(EPRX.WT.A) Investment Analysis and Advice - Stock Traders Daily
(EPRX) Technical Pivots with Risk Controls (EPRX:CA) - news.stocktradersdaily.com
Analysts see more than 77% upside for Eupraxia Pharmaceuticals (EPRX), here’s why - MSN
CapEx per share of Eupraxia Pharmaceuticals Inc Warrant 2021-09.03.2026 on Eupraxia Pharma Rg – TSX:EPRX.WT - TradingView
Is Eupraxia Pharmaceuticals Inc. stock oversold or undervaluedWeekly Trade Review & Verified Technical Signals - Newser
Will Eupraxia Pharmaceuticals Inc. (X43) stock outperform global peersJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why - Finviz
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here’s Why - Yahoo Finance
Eupraxia Pharmaceuticals Inc (EPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):